Company Overview - Brighthouse Financial, spun out of MetLife in 2017, operates in life insurance and asset management, with a current stock price around $60 per share, presenting a potential 15% gain for investors [1][3]. Acquisition Update - Brighthouse Financial's shareholders have approved the acquisition by Aquarian Capital, with the purchase price set at $70 per share, pending regulatory approvals expected in 2026 [2][3]. Potential Gains - The anticipated 15% gain from the acquisition is significant, especially considering that typical stock returns are around 10% annually. The merger arbitrage opportunity could yield this return in less than a year, potentially increasing the annualized return [4]. Market Sentiment - The current market price is below the agreed acquisition price, indicating concerns among investors regarding the likelihood of regulatory approval for the deal [5]. Risk Factors - If Aquarian Capital withdraws from the acquisition, Brighthouse Financial's stock could drop to approximately $48 per share, representing a potential loss of 20% from the current price [6].